Zydus Cadila gets US Food and Drug Administration nod for diabetes medication

On October 31, 2020, Zydus had filed a new drug application (NDA) with the USFDA seeking approval to market Sitagliptin base 25, 50 and 100 mg tablets.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3kWGnbx
via IFTTT